Viatris Inc

Viatris Inc VTRS

Dividend Summary

The next Viatris Inc dividend went ex 5 days ago for 12c and will be paid in 19 days.
The previous Viatris Inc dividend was 12c and it went ex 3 months ago and it was paid 2 months ago.
There are typically 4 dividends per year (excluding specials).

Latest Dividends
Summary Previous dividend Next dividend
Status Paid Declared
Type Quarterly Quarterly
Per share 12c 12c
Declaration date 24 Feb 2023 (Fri) 05 May 2023 (Fri)
Ex-div date 08 Mar 2023 (Wed) 23 May 2023 (Tue)
Pay date 17 Mar 2023 (Fri) 16 Jun 2023 (Fri)

Enter the number of Viatris Inc shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
94%
Our premium tools have predicted Viatris Inc with 94% accuracy.
Dividend Yield Today
5.3%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Viatris Inc
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Forecast Quarterly 18 Feb 2028 01 Mar 2028 10 Mar 2028 USD Sign up
Forecast Quarterly 01 Nov 2027 16 Nov 2027 10 Dec 2027 USD Sign up
Forecast Quarterly 29 Jul 2027 17 Aug 2027 10 Sep 2027 USD Sign up
Forecast Quarterly 30 Apr 2027 18 May 2027 11 Jun 2027 USD Sign up
Forecast Quarterly 19 Feb 2027 03 Mar 2027 12 Mar 2027 USD Sign up
Forecast Quarterly 02 Nov 2026 17 Nov 2026 11 Dec 2026 USD Sign up
Forecast Quarterly 30 Jul 2026 18 Aug 2026 11 Sep 2026 USD Sign up
Forecast Quarterly 01 May 2026 19 May 2026 12 Jun 2026 USD Sign up
Forecast Quarterly 20 Feb 2026 04 Mar 2026 13 Mar 2026 USD Sign up
Forecast Quarterly 03 Nov 2025 18 Nov 2025 12 Dec 2025 USD Sign up
Forecast Quarterly 31 Jul 2025 19 Aug 2025 12 Sep 2025 USD Sign up
Forecast Quarterly 02 May 2025 20 May 2025 13 Jun 2025 USD Sign up
Forecast Quarterly 21 Feb 2025 05 Mar 2025 14 Mar 2025 USD Sign up
Forecast Quarterly 04 Nov 2024 19 Nov 2024 13 Dec 2024 USD Sign up
Forecast Quarterly 01 Aug 2024 20 Aug 2024 13 Sep 2024 USD Sign up
Forecast Quarterly 03 May 2024 21 May 2024 14 Jun 2024 USD Sign up
Forecast Quarterly 23 Feb 2024 06 Mar 2024 15 Mar 2024 USD Sign up
Forecast Quarterly 06 Nov 2023 21 Nov 2023 15 Dec 2023 USD Sign up
Forecast Quarterly 03 Aug 2023 22 Aug 2023 15 Sep 2023 USD Sign up
Declared Quarterly 05 May 2023 23 May 2023 16 Jun 2023 USD 13c 12c 😊
Paid Quarterly 24 Feb 2023 08 Mar 2023 17 Mar 2023 USD 13c 12c 😊
Paid Quarterly 07 Nov 2022 22 Nov 2022 16 Dec 2022 USD 12c 12c 😄
Paid Quarterly 04 Aug 2022 23 Aug 2022 16 Sep 2022 USD 12c 12c 😄
Paid Quarterly 05 May 2022 23 May 2022 16 Jun 2022 USD 12c 12c 😄
Paid Quarterly 06 Jan 2022 23 Feb 2022 16 Mar 2022 USD 11c 12c 😊
Paid Quarterly 08 Nov 2021 22 Nov 2021 16 Dec 2021 USD 11c 11c 😄
Paid Quarterly 09 Aug 2021 23 Aug 2021 16 Sep 2021 USD 11c 11c 😄
Paid Quarterly 10 May 2021 21 May 2021 16 Jun 2021 USD 11c
Year Amount Change
2006 0.0c
2007 0.0c
0%
2008 0.0c
0%
2009 0.0c
0%
2010 0.0c
0%
2011 0.0c
0%
2012 0.0c
0%
2013 0.0c
0%
2014 0.0c
0%
2015 0.0c
0%
2016 0.0c
0%
2017 0.0c
0%
2018 0.0c
0%
2019 0.0c
0%
2020 0.0c
0%
2021 45.0c
100%
2022 48.0c
6.7%
2023 Sign Up Required
2024 Sign Up Required
2025 Sign Up Required
2026 Sign Up Required
2027 Sign Up Required

Viatris Inc Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
5.3%
Optimized Yield
Sign Up Required
52 Week High
7.9% on 04 May 2023
52 Week Low
4.2% on 28 May 2022
Next Ex-Div-Date Countdown
Sign Up Required

About Viatris Inc

Viatris Inc. is a global healthcare company. The Company has four segments: Developed Markets, Greater China, JANZ and Emerging Markets. Developed Markets segment comprises its operations primarily in North America and Europe. Greater China segment includes its operations in China, Taiwan and Hong Kong. JANZ segment reflects its operations in Japan, Australia and New Zealand. Emerging Markets segment encompasses its presence in approximately 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East, as well as its anti-retroviral franchise. Its portfolio comprises approximately 1,400 approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands, generics, complex generics, and biosimilars. It operates approximately 40 manufacturing sites worldwide, which produces oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients.

Sector
Pharmaceuticals & Biotechnology
Country
United States
Share Price
$9.11 (yesterday's closing price)
Shares in Issue
1,199 million
Market Cap
$10.9bn
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
2
Market Indices
S&P 500
No articles found